We are live on
!
Find out more
PCM
Pentwater Capital Management Portfolio holdings
AUM
$19.3B
1-Year Est. Return
58.13%
This Fund
S&P 500
This Quarter
Est. Return
+11.49%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$10.8B
AUM Growth
+$3.3B
(+44%)
Cap. Flow
+$2.87B
Cap. Flow
% of AUM
26.66%
Top 10 Holdings %
Top 10 Hldgs %
66.63%
Holding
159
New
58
Increased
20
Reduced
30
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.66B |
| 2 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$220M |
| 3 |
Dell
DELL
|
+$209M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$197M |
| 5 |
Coty
COTY
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$614M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$258M |
| 3 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$132M |
| 4 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$98.4M |
| 5 |
AGN
Allergan plc
AGN
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 19.59% |
| 2 | Healthcare | 8.57% |
| 3 | Communication Services | 7.11% |
| 4 | Technology | 3.64% |
| 5 | Materials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $1.83B | 16.97% |
8,460,000
+1,830,000
| +28% | +$396M |
|
|
2
Procter & Gamble
PG
$343B
| $1.72B | 15.96% |
+19,167,407
| New | +$1.66B |
|
|
3
PUT
Procter & Gamble
PG
$343B
| $1.27B | 11.81% |
+14,190,000
| New | +$1.23B |
|
|
LNKD
4
DELISTED
LinkedIn Corporation
LNKD
| $693M | 6.43% |
3,628,000
+1,026,501
| +39% | +$197M |
|
5
PUT
Humana
HUM
$46.7B
| $407M | 3.77% |
2,300,000
-290,000
| -11% | -$50.3M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $325M | 3.02% |
1,413,000
-347,868
| -20% | -$85M |
|
|
TRQ
7
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $282M | 2.62% |
9,500,300
+312,300
| +3% | +$10.1M |
|
8
Synchrony
SYF
$23.7B
| $227M | 2.11% |
8,123,415
+503
| +0% | +$13.8K |
|
|
WWAV
9
DELISTED
The WhiteWave Foods Company
WWAV
| $218M | 2.02% |
+4,000,000
| New | +$220M |
|
|
AGN
10
CALL
DELISTED
Allergan plc
AGN
| $207M | 1.92% |
900,000
-280,000
| -24% | -$68.4M |
|
|
11
Dell
DELL
$283B
| $206M | 1.91% |
+15,375,700
| New | +$209M |
|
|
12
Coty
COTY
$2.33B
| $174M | 1.61% |
+7,396,857
| New | +$195M |
|
|
AGN
13
PUT
DELISTED
Allergan plc
AGN
| $164M | 1.52% |
712,000
-50,000
| -7% | -$12.2M |
|
|
14
Humana
HUM
$46.7B
| $159M | 1.48% |
900,000
-427,500
| -32% | -$74.2M |
|
|
RAD
15
DELISTED
Rite Aid Corporation
RAD
| $154M | 1.43% |
1,000,000
+7,500
| +0.8% | +$1.12M |
|
|
16
PUT
Synchrony
SYF
$23.7B
| $154M | 1.43% |
5,489,300
+1,212,400
| +28% | +$33.3M |
|
17
CALL
Pfizer
PFE
$140B
| $153M | 1.42% |
4,757,651
-1,250,149
| -21% | -$41.8M |
|
|
TBRA
18
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $147M | 1.36% |
+3,698,719
| New | +$41.3M |
|
|
RAD
19
PUT
DELISTED
Rite Aid Corporation
RAD
| $119M | 1.1% |
772,500
+72,500
| +10% | +$10.8M |
|
20
PUT
Bausch Health
BHC
$1.65B
| $92.6M | 0.86% |
3,770,300
| – | – |
|
21
NXP Semiconductors
NXPI
$68B
| $90.8M | 0.84% |
+890,000
| New | +$75.4M |
|
|
22
PUT
NXP Semiconductors
NXPI
$68B
| $82.6M | 0.77% |
+810,000
| New | +$68.6M |
|
|
ALR
23
DELISTED
Alere Inc
ALR
| $80.4M | 0.75% |
1,860,000
-1,340,000
| -42% | -$54.7M |
|
|
24
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $80M | 0.74% |
+370,000
| New | +$80M |
|
25
PUT
Charter Communications
CHTR
$15.2B
| $77.8M | 0.72% |
288,000
-21,000
| -7% | -$5.3M |
|
Similar funds
CS
MGP
A
LF
MIM
SPIA
SOMRS
Pentwater Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Pentwater Capital Management held 159 positions worth $10.8B, up 44% from $7.49B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Pentwater Capital Management deployed $2.87B of net new capital in Q3 2016, opening 58 new positions and adding to 20 existing holdings. Its largest new stake was Procter & Gamble: 19,167,407 shares worth $1.72B.
By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 0% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Allergan plc, an estimated $85M trimmed.
- Pentwater Capital Management's largest Q3 2016 buy was Procter & Gamble: 19,167,407 shares worth $1.72B.
- Pentwater Capital Management added most to LinkedIn Corporation in Q3 2016, an estimated $197M increase.
- Pentwater Capital Management's biggest Q3 2016 reduction was Allergan plc, cutting an estimated $85M.
- Pentwater Capital Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $614M.
- Pentwater Capital Management's ten largest holdings make up 67% of its $10.8B portfolio in Q3 2016.
- Pentwater Capital Management opened 58 new positions and closed 38 in Q3 2016.
- Pentwater Capital Management's portfolio value rose 44% quarter-over-quarter to $10.8B.
Based on Pentwater Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.